Copertina

Natural products: Call for hard evidence

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autore principale:	Francesco Visioli
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Natural product pharmacology: the British Journal of Pharmacology perspective
di: Xin Wang, et al.
Pubblicazione: (2024)

Natural products and cancer: From drug discovery to prevention and therapy
di: Angelo A. Izzo, et al.
Pubblicazione: (2025)

5‐HT 2A receptor agonism by tert ‐leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence
di: Giorgia Corli, et al.
Pubblicazione: (2026)

Intranasal bumetanide in heart failure: Innovation ahead of evidence
di: Zehra Sadia, et al.
Pubblicazione: (2025)

Updated BJP guidelines for transparent and rigorous natural product research
di: Xin Wang, et al.
Pubblicazione: (2026)

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
di: Rao Hu, et al.
Pubblicazione: (2026)

Digital twins: Unlocking comparative evidence that clinical research urgently needs
di: Andrej Belančić, et al.
Pubblicazione: (2025)

Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways
di: Paola Rogliani, et al.
Pubblicazione: (2025)

Recent advances in neuroinflammation prevention and therapy: the role of natural products and underlying mechanisms based on molecular targets
di: Mei‐Mei Zhao, et al.
Pubblicazione: (2024)

Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin‐based therapies
di: Ilaria Serra, et al.
Pubblicazione: (2026)

Generating and translating evidence for safe and effective medication management in aged care homes
di: Annie M. L. Ea, et al.
Pubblicazione: (2024)

D‐amino acid oxidase as a chemogenetic tool for spatiotemporally controlled hydrogen peroxide production: The oxygen connection
di: Wiebke Maurer, et al.
Pubblicazione: (2025)

Adherence to evidence‐based practice in the treatment of digoxin poisoning in New South Wales, Australia
di: Betty S. Chan, et al.
Pubblicazione: (2025)

Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance
di: Ignatios Ioakeim‐Skoufa, et al.
Pubblicazione: (2025)

Drug safety signals in breastfeeding: Bridging evidence from European and US pharmacovigilance systems
di: Hülya Tezel Yalçın, et al.
Pubblicazione: (2025)

P2X7 receptor‐dependent increase in endocannabinoid 2‐arachidonoyl glycerol production by neuronal cells in culture: Dynamics and mechanism
di: Simar Singh, et al.
Pubblicazione: (2024)

GLP‐1 receptor agonists and reduced dementia risk: Real‐world evidence stacks up
di: Yun Wah Lam, et al.
Pubblicazione: (2026)

β 3 ‐adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia
di: Alessandro Pini, et al.
Pubblicazione: (2026)

Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis
di: Yijun Pan, et al.
Pubblicazione: (2025)

Evaluating the capability of ChatGPT in predicting drug–drug interactions: Real‐world evidence using hospitalized patient data
di: Ramya Padmavathy Radha Krishnan, et al.
Pubblicazione: (2024)

Mindfulness‐Oriented Recovery Enhancement: Implementing an evidence‐based intervention for chronic pain, opioid use, and opioid addiction in clinical settings
di: Eric L. Garland
Pubblicazione: (2024)

Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus
di: Chih‐Jia Chao, et al.
Pubblicazione: (2024)

Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review
di: Dhrita Khatri, et al.
Pubblicazione: (2024)

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review
di: Alessio Provenzani, et al.
Pubblicazione: (2025)

Modulation of K ATP channels by diazoxide preserves mitochondrial function and barrier integrity under staurosporine‐induced epithelial stress
di: Fatima Maqoud, et al.
Pubblicazione: (2026)

The clinical toxicity of advanced therapy medicinal products
di: Fraser J. H. Henderson, et al.
Pubblicazione: (2025)

Time to accelerate rare disease research: AI‐powered in silico trials, digital twin‐driven RCTs and decision‐grade real‐world evidence
di: Andrej Belančić, et al.
Pubblicazione: (2026)

Letter to the editor: Expanding DPYD genotyping panels beyond current guidelines—real‐world evidence and clinical–economic thoughts on inclusion of additional variants
di: Silvestar Mežnarić, et al.
Pubblicazione: (2025)

Memantine prevents acute stress‐induced memory deficits by reversing sex‐dependent pathophysiological glutamatergic alterations in the dorsal hippocampus
di: Sebastiano A. Torrisi, et al.
Pubblicazione: (2026)

The fast‐dissociating D 2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment
di: Lidia Carotenuto, et al.
Pubblicazione: (2025)

Advanced therapy medicinal products (ATMPs) – An analysis of the global regulatory status
di: Allan Cramer, et al.
Pubblicazione: (2026)

Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in pregnant women with HIV
Pubblicazione: (2024)

A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia
di: Laura Latini, et al.
Pubblicazione: (2024)

Schwann cell TRPA1 elicits reserpine‐induced fibromyalgia pain in mice
di: Evelyne Silva Brum, et al.
Pubblicazione: (2024)

Pharmacological evaluation of non‐nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury
di: Inés Valencia, et al.
Pubblicazione: (2025)

On the use of open‐label studies for the evaluation of cannabis‐based products for the treatment of long COVID
di: Andriy A. Gorbenko, et al.
Pubblicazione: (2024)

Sustainable medicines development and use: Challenges and opportunities in the sustainable production of active pharmaceutical ingredients
di: Gary M. Noonan, et al.
Pubblicazione: (2024)

Anti‐nociceptive action of leonurine through TRPA1 and TRPV4 channels modulation
di: Matilde Marini, et al.
Pubblicazione: (2025)

Development of method using language processing techniques for extracting information on drug–health food product interactions
di: Mari Yoshizaki, et al.
Pubblicazione: (2024)

The use of C‐reactive protein testing and antibiotic prescribing in Italy: A population‐based study in primary care
di: Francesco Lapi, et al.
Pubblicazione: (2024)